Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 103 participants.
Also called NCT03433274
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 103 participants
- Sponsor
- Registry
-
NCT03433274
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03433274. Randomized; no masking; primary purpose treatment. Start 2018-06-15 (actual); primary completion 2024-04-29 (actual). Results posted on 2026-01-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
- Acronym
- SUMMIT
- Condition
- Mitral Regurgitation
- Condition
- Mitral Insufficiency
- Condition
- Mitral Valve Insufficiency
- Condition
- Cardiovascular Diseases
- Condition
- Valve Disease, Heart
- Condition
- Heart Valve Diseases
- Condition
- Functional Mitral Regurgitation
- Condition
- Degenerative Mitral Valve Disease
- Intervention (Device)
- Tendyne Mitral Valve System
- Intervention (Device)
- MitraClip System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct03433274- Content hash
04d9b257ff5fe0fa33bfbc422b52eaa0bfc3e15a6372c7ec07c95fe300d3108c